Managing Toxicities from Chronic Myeloid Leukemia Treatment
2 Tampilan
• 07/08/23
0
0
Menanamkan
administrator
Pelanggan
The panelists, Jorge Cortes, MD; Javier Pinilla-Ibarz, MD, PhD; Kevin Kelly, MD, PhD; David Snyder, MD, FACP; and Harry Erba, MD, PhD, comment on strategies to manage adverse events from tyrosine kinase inhibitor therapy used in the treatment of chronic myeloid leukemia.
Menampilkan lebih banyak
Komentar Facebook
SORT BY-
Komentar Teratas
-
komentar terbaru